Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Jean-Jacques Murama
Advertisement
Associate Vice President, Global Medical Affairs Education, Eli Lilly
Articles by Jean-Jacques Murama
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data
2
Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s
3
Why Real-Time Data Analytics Are Vital for the Next Evolution of Clinical Trials
4
FDA CTGTAC Committee Votes in Favor of Replimune’s RP1 Efficiency Results in Ignyte Study
5